Moore JP - Search Results

1

HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy.

Morris L, Binley JM, Clas BA, Bonhoeffer S, Astill TP, Kost R, Hurley A, Cao Y, Markowitz M, Ho DD, Moore JP. Morris L, et al. Among authors: moore jp. J Exp Med. 1998 Jul 20;188(2):233-45. doi: 10.1084/jem.188.2.233. J Exp Med. 1998. PMID: 9670036 Free PMC article. Clinical Trial.

2

HIV-negative AIDS.

Moore JP, Ho DD. Moore JP, et al. Lancet. 1992 Aug 22;340(8817):475. doi: 10.1016/0140-6736(92)91784-6. Lancet. 1992. PMID: 1354796 No abstract available.

3

Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.

Moore JP, McKeating JA, Huang YX, Ashkenazi A, Ho DD. Moore JP, et al. J Virol. 1992 Jan;66(1):235-43. doi: 10.1128/JVI.66.1.235-243.1992. J Virol. 1992. PMID: 1727487 Free PMC article.

4

Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop.

Yoshiyama H, Mo H, Moore JP, Ho DD. Yoshiyama H, et al. Among authors: moore jp. J Virol. 1994 Feb;68(2):974-8. doi: 10.1128/JVI.68.2.974-978.1994. J Virol. 1994. PMID: 7507188 Free PMC article.

5

Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assays.

Moore JP, Cao Y, Conley AJ, Wyatt R, Robinson J, Gorny MK, Zolla-Pazner S, Ho DD, Koup RA. Moore JP, et al. J Acquir Immune Defic Syndr (1988). 1994 Apr;7(4):332-9. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7510807

6

Antigenic variation in gp120s from molecular clones of HIV-1 LAI.

Moore JP, Yoshiyama H, Ho DD, Robinson JE, Sodroski J. Moore JP, et al. AIDS Res Hum Retroviruses. 1993 Dec;9(12):1185-93. doi: 10.1089/aid.1993.9.1185. AIDS Res Hum Retroviruses. 1993. PMID: 7511394

7

Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies.

Moore JP, McCutchan FE, Poon SW, Mascola J, Liu J, Cao Y, Ho DD. Moore JP, et al. J Virol. 1994 Dec;68(12):8350-64. doi: 10.1128/JVI.68.12.8350-8364.1994. J Virol. 1994. PMID: 7525988 Free PMC article.

8

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.

Moore JP, Cao Y, Qing L, Sattentau QJ, Pyati J, Koduri R, Robinson J, Barbas CF 3rd, Burton DR, Ho DD. Moore JP, et al. J Virol. 1995 Jan;69(1):101-9. doi: 10.1128/JVI.69.1.101-109.1995. J Virol. 1995. PMID: 7527081 Free PMC article.

9

A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B.

Moore JP, Trkola A, Korber B, Boots LJ, Kessler JA 2nd, McCutchan FE, Mascola J, Ho DD, Robinson J, Conley AJ. Moore JP, et al. J Virol. 1995 Jan;69(1):122-30. doi: 10.1128/JVI.69.1.122-130.1995. J Virol. 1995. PMID: 7527082 Free PMC article.

10

Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.

Ditzel HJ, Binley JM, Moore JP, Sodroski J, Sullivan N, Sawyer LS, Hendry RM, Yang WP, Barbas CF 3rd, Burton DR. Ditzel HJ, et al. Among authors: moore jp. J Immunol. 1995 Jan 15;154(2):893-906. J Immunol. 1995. PMID: 7529290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

769 results

Search Page

Filters